BackBenitec Biopharma Overview

Benitec Biopharma Current Cash

Track Benitec Biopharma's current cash ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$184.76M
↑ 78.37% YoYΔ $81.18M vs prior year quarter

Peer average

Loading

Benitec Biopharma Current Cash History

Loading

Benitec Biopharma vs. peers: Current Cash Comparison

Loading

Benitec Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Benitec Biopharma (BNTC) FAQ

Benitec Biopharma (BNTC) currently reports a current cash of $180M as of March 2026. That compares with $100M in the prior-year period — up 78.4% year over year. Use the charts on this page to explore Benitec Biopharma's current cash history and peer comparisons.

Benitec Biopharma's current cash increased from $100M to $180M — a 78.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Benitec Biopharma reported $180M in current cash as of March 2026. That compares with $100M in the prior-year period — up 78.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Benitec Biopharma, and consider following BNTC for alerts when major investors trade the stock.